Amendment and Mail Process Complete

PLATO

AVROBIO, Inc.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88276835 FILING DATE 01/25/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY NEVILLE, JAMES B
L.O. ASSIGNED 114

PUB INFORMATION

RUN DATE 06/22/2019
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 06/21/2019
LITERAL MARK ELEMENT PLATO

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT PLATO
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME AVROBIO, Inc.
ADDRESS Building 300, Suite 201
One Kendall Square
Cambridge, MA 02139
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Platform as a service (PAAS) featuring gene therapy development platforms for treatments for rare and other diseases

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
06/21/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 008
06/20/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 007
06/20/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 006
04/12/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 005
04/12/2019 GNRT F NON-FINAL ACTION E-MAILED 004
04/12/2019 CNRT R NON-FINAL ACTION WRITTEN 003
04/08/2019 DOCK D ASSIGNED TO EXAMINER 002
02/17/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Michael J. Belliveau
CORRESPONDENCE ADDRESS MICHAEL J. BELLIVEAU
CLARK+ELBING LLP
101 FEDERAL STREET, 15TH FLOOR
BOSTON, MA 02110
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed